Luminex Corp. (LMNX) Misses Q4 EPS by 12c, Revenue Beats, Offers Guidance

Luminex Corp. (NASDAQ: LMNX) reported Q4 EPS of $0.01, $0.12 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $111.4 million versus the consensus estimate of $104.57 million.

GUIDANCE:

Luminex Corp. sees 2021 revenue of $480 million vs $474.4 million consensus.

• Luminex reaffirms its 2021 revenue expectations of approximately $480 million, reflecting 15% growth over Luminex's full year 2020, with such revenue growth driven primarily by significant expansion of ARIES® assay sales resulting from completion of the manufacturing line expansion, an expanded customer base, and new product launches.

For earnings history and earnings-related data on Luminex Corp. (LMNX) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Customers Bancorp (CUBI) Tops Q1 EPS by 3c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c